Richters A, Aben KKH, Kiemeney L. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–904. https://doi.org/10.1007/s00345-019-02984-4.
Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. https://doi.org/10.1038/nrdp.2017.22.
Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus calmette-guerin. Eur Urol. 2016;69(1):60–9. https://doi.org/10.1016/j.eururo.2015.06.045.
Wilson F, Joseph N, Choudhury A. Biomarkers in muscle invasive bladder cancer. Adv Clin Chem. 2022;107:265–97. https://doi.org/10.1016/bs.acc.2021.07.005.
Chen S, Gu J, Zhang Q, Hu Y, Ge Y. Development of biomarker signatures associated with anoikis to predict prognosis in endometrial carcinoma patients. J Oncol. 2021;2021:3375297. https://doi.org/10.1155/2021/3375297.
Article PubMed PubMed Central Google Scholar
Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X. Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol. 2021;11:626577. https://doi.org/10.3389/fonc.2021.626577.
Article PubMed PubMed Central Google Scholar
Du S, Yang Z, Lu X, Yousuf S, Zhao M, Li W, et al. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPbeta-mediated PDGFB autocrine and paracrine signaling. Oncogene. 2021;40(38):5764–79. https://doi.org/10.1038/s41388-021-01988-y.
Zhu Z, Fang C, Xu H, Yuan L, Du Y, Ni Y, et al. Anoikis resistance in diffuse glioma: the potential therapeutic targets in the future. Front Oncol. 2022;12:976557. https://doi.org/10.3389/fonc.2022.976557.
Article PubMed PubMed Central Google Scholar
Lee HY, Son SW, Moeng S, Choi SY, Park JK. The role of noncoding RNAs in the regulation of anoikis and anchorage-independent growth in cancer. Int J Mol Sci. 2021;22(2). https://doi.org/10.3390/ijms22020627.
Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M, et al. Comparative analysis of single-cell RNA sequencing methods. Mol Cell. 2017;65(4):631-643 e634. https://doi.org/10.1016/j.molcel.2017.01.023.
Kolodziejczyk AA, Kim JK, Svensson V, Marioni JC, Teichmann SA. The technology and biology of single-cell RNA sequencing. Mol Cell. 2015;58(4):610–20. https://doi.org/10.1016/j.molcel.2015.04.005.
Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y. Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med. 2022;12(3):e694. https://doi.org/10.1002/ctm2.694.
Article PubMed PubMed Central Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007.
Article PubMed PubMed Central Google Scholar
Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–3. https://doi.org/10.1093/bioinformatics/bts034.
Article PubMed PubMed Central Google Scholar
Zhang H, Meltzer P, Davis S. RCircos: an R package for Circos 2D track plots. BMC Bioinformatics. 2013;14:244. https://doi.org/10.1186/1471-2105-14-244.
Article PubMed PubMed Central Google Scholar
Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016;374(2065):20150202. https://doi.org/10.1098/rsta.2015.0202.
Article PubMed PubMed Central Google Scholar
Pezzotti N, Lelieveldt BPF, Van Der Maaten L, Hollt T, Eisemann E, Vilanova A. Approximated and user steerable tSNE for progressive visual analytics. IEEE Trans Vis Comput Graph. 2017;23(7):1739–52. https://doi.org/10.1109/TVCG.2016.2570755.
Armstrong G, Martino C, Rahman G, Gonzalez A, Vazquez-Baeza Y, Mishne G, et al. Uniform manifold approximation and projection (UMAP) reveals composite patterns and resolves visualization artifacts in microbiome data. mSystems. 2021;6(5):e0069121. https://doi.org/10.1128/mSystems.00691-21.
Zhao Z, Liu H, Zhou X, Fang D, Ou X, Ye J, et al. Necroptosis-related lncRNAs: predicting prognosis and the distinction between the cold and hot tumors in gastric cancer. J Oncol. 2021;2021:6718443. https://doi.org/10.1155/2021/6718443.
Article PubMed PubMed Central Google Scholar
Meng T, Huang R, Zeng Z, Huang Z, Yin H, Jiao C, et al. Identification of prognostic and metastatic alternative splicing signatures in kidney renal clear cell carcinoma. Front Bioeng Biotechnol. 2019;7:270. https://doi.org/10.3389/fbioe.2019.00270.
Article PubMed PubMed Central Google Scholar
Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https://doi.org/10.1038/ncomms3612.
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7. https://doi.org/10.1038/nmeth.3337.
Article PubMed PubMed Central Google Scholar
Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51(D1):D1425–31. https://doi.org/10.1093/nar/gkac959.
Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833(12):3481–98. https://doi.org/10.1016/j.bbamcr.2013.06.026.
Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226(2):380–93. https://doi.org/10.1002/path.3000.
Zhang H, Wang G, Zhou R, Li X, Sun Y, Li Y, et al. SPIB promotes anoikis resistance via elevated autolysosomal process in lung cancer cells. FEBS J. 2020;287(21):4696–709. https://doi.org/10.1111/febs.15272.
Valentijn AJ, Zouq N, Gilmore AP. Anoikis. Biochem Soc Trans. 2004;32(Pt3):421–5. https://doi.org/10.1042/BST0320421.
Zhi Z, Ouyang Z, Ren Y, Cheng Y, Liu P, Wen Y, et al. Non-canonical phosphorylation of Bmf by p38 MAPK promotes its apoptotic activity in anoikis. Cell Death Differ. 2022;29(2):323–36. https://doi.org/10.1038/s41418-021-00855-3.
Jin L, Chun J, Pan C, Alesi GN, Li D, Magliocca KR, et al. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene. 2017;36(27):3797–806. https://doi.org/10.1038/onc.2017.6.
Article PubMed PubMed Central Google Scholar
Xu R, Yan Y, Zheng X, Zhang H, Chen W, Li H, et al. Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance. Carcinogenesis. 2022;43(2):104–14. https://doi.org/10.1093/carcin/bgab117.
Frankel A, Rosen K, Filmus J, Kerbel RS. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L). Cancer Res. 2001;61(12):4837–41.
Toricelli M, Melo FH, Peres GB, Silva DC, Jasiulionis MG. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol Cancer. 2013;12:22. https://doi.org/10.1186/1476-4598-12-22.
Article PubMed PubMed Central Google Scholar
Markouli M, Strepkos D, Basdra EK, Papavassiliou AG, Piperi C. Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis. Int J Mol Sci. 2021;22(5). https://doi.org/10.3390/ijms22052778.
Lu Q, Wang L, Gao Y, Zhu P, Li L, Wang X, et al. lncRNA APOC1P1–3 promoting anoikis-resistance of breast cancer cells. Cancer Cell Int. 2021;21(1):232. https://doi.org/10.1186/s12935-021-01916-w.
Article PubMed PubMed Central Google Scholar
Egan CE, Stefanova D, Ahmed A, Raja VJ, Thiesmeyer JW, Chen KJ, et al. CSPG4 is a potential therapeutic target in anaplastic thyroid cancer. Thyroid. 2021;31(10):1481–93. https://doi.org/10.1089/thy.2021.0067.
Article PubMed PubMed Central Google Scholar
Kim HY, Han Y, Jang JH, Jung CW, Kim SH, Kim HJ. Effects of CALR-Mutant type and burden on the phenotype of myeloproliferative neoplasms. Diagnostics (Basel).2022;12(11). https://doi.org/10.3390/diagnostics12112570.
Olschok K, Han L, de Toledo MAS, Bohnke J, Grasshoff M, Costa IG, et al. CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes. Stem Cell Rep. 2021;16(11):2768–83. https://doi.org/10.1016/j.stemcr.2021.09.019.
Liu R, Li R, Yu H, Liu J, Zheng S, Li Y, et al. NTF3 correlates with prognosis and immune infiltration in hepatocellular carcinoma. Front Med (Lausanne). 2021;8:795849. https://doi.org/10.3389/fmed.2021.795849.
Comments (0)